ArticleFrontiers in oncology2021

Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?

Christine A Fargeas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.